D Roy

Summary

Country: Canada

Publications

  1. ncbi Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial
    Denis Roy
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Card Electrophysiol Rev 7:208-10. 2003
  2. ncbi Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
    D Roy
    Montreal Heart Institute, QC, Canada
    N Engl J Med 342:913-20. 2000
  3. ncbi Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial
    G B Lumer
    Research Center, Montreal, Quebec, Canada
    Eur Heart J 23:1050-6. 2002
  4. doi Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms
    O Naggara
    Department of Radiology, Interventional Neuroradiology Research Unit, International Consortium of Neuroendovascular Centres, University of Montreal, CHUM Notre Dame Hospital, Quebec, Canada
    AJNR Am J Neuroradiol 32:437-40. 2011
  5. ncbi Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs
    M Dubuc
    Department of Medicine, Montreal Heart Institute, Quebec, Canada
    Pacing Clin Electrophysiol 22:1488-98. 1999
  6. ncbi Catheter cryoablation of the atrioventricular node in patients with atrial fibrillation: a novel technology for ablation of cardiac arrhythmias
    M Dubuc
    Research Center, Montreal Heart Institute, Quebec, Canada
    J Cardiovasc Electrophysiol 12:439-44. 2001
  7. ncbi Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia
    A C Skanes
    Arrhythmia Services, University of Western Ontario, Montreal, Quebec, Canada
    Circulation 102:2856-60. 2000
  8. ncbi Laser lead extraction: predictors of success and complications
    Jean Francois Roux
    Electrophysiology Service, Department of Cardiology, Montreal Heart Institute, Montreal, Canada
    Pacing Clin Electrophysiol 30:214-20. 2007
  9. pmc A randomized trial on the safety and efficacy of endovascular treatment of unruptured intracranial aneurysms is feasible
    J Raymond
    CHUM Notre Dame Hospital, Radiology Department, Université de Montréal Montréal, Quebec, Canada
    Interv Neuroradiol 10:103-12. 2004
  10. pmc Flow diversion in aneurysms trial: the design of the FIAT study
    J Raymond
    Centre Hospitalier de l Universite de Montreal CHUM, Notre Dame Hospital, Department of Radiology and Interventional Neuroradiology Research Unit, Montreal, Quebec, Canada
    Interv Neuroradiol 17:147-53. 2011

Collaborators

Detail Information

Publications57

  1. ncbi Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial
    Denis Roy
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Card Electrophysiol Rev 7:208-10. 2003
    ..As of December 2003, 960 patients have been randomized. Enrollment is expected to be completed in September 2004 with a minimum follow-up of 2 years...
  2. ncbi Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
    D Roy
    Montreal Heart Institute, QC, Canada
    N Engl J Med 342:913-20. 2000
    ..Uncontrolled studies have suggested that amiodarone in low doses may be more effective and safer than other agents in preventing recurrence, but this agent has not been tested in a large, randomized trial...
  3. ncbi Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial
    G B Lumer
    Research Center, Montreal, Quebec, Canada
    Eur Heart J 23:1050-6. 2002
    ..The impact of various treatment options for atrial fibrillation on hospital costs has not been evaluated in a randomized trial...
  4. doi Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms
    O Naggara
    Department of Radiology, Interventional Neuroradiology Research Unit, International Consortium of Neuroendovascular Centres, University of Montreal, CHUM Notre Dame Hospital, Quebec, Canada
    AJNR Am J Neuroradiol 32:437-40. 2011
    ..Categorization of continuous data, especially dichotomization, is unnecessary for statistical analysis. Continuous explanatory variables should be left alone in statistical models...
  5. ncbi Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs
    M Dubuc
    Department of Medicine, Montreal Heart Institute, Quebec, Canada
    Pacing Clin Electrophysiol 22:1488-98. 1999
    ..Ablation of the AV node is effective with a double freeze-thaw cycle using a percutaneous catheter cryoablation system. Ice mapping of the area allows for identification of the targeted site...
  6. ncbi Catheter cryoablation of the atrioventricular node in patients with atrial fibrillation: a novel technology for ablation of cardiac arrhythmias
    M Dubuc
    Research Center, Montreal Heart Institute, Quebec, Canada
    J Cardiovasc Electrophysiol 12:439-44. 2001
    ..The studies also showed that reversible "ice mapping" can be performed before creating permanent lesions. We investigated the feasibility and safety of applying this new technology in man...
  7. ncbi Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia
    A C Skanes
    Arrhythmia Services, University of Western Ontario, Montreal, Quebec, Canada
    Circulation 102:2856-60. 2000
    ..We report the first successful slow pathway ablation using a novel catheter-based cryothermal technology for the elimination of atrioventricular nodal reentrant tachycardia (AVNRT)...
  8. ncbi Laser lead extraction: predictors of success and complications
    Jean Francois Roux
    Electrophysiology Service, Department of Cardiology, Montreal Heart Institute, Montreal, Canada
    Pacing Clin Electrophysiol 30:214-20. 2007
    ..Paralleling the rise in pacemaker and defibrillator implantations, lead extraction procedures are increasingly required. Concerns regarding failure and complications remain...
  9. pmc A randomized trial on the safety and efficacy of endovascular treatment of unruptured intracranial aneurysms is feasible
    J Raymond
    CHUM Notre Dame Hospital, Radiology Department, Université de Montréal Montréal, Quebec, Canada
    Interv Neuroradiol 10:103-12. 2004
    ..A randomized trial comparing endovascular and conservative treatment could have an important impact on the clinical management of intracranial aneurysms...
  10. pmc Flow diversion in aneurysms trial: the design of the FIAT study
    J Raymond
    Centre Hospitalier de l Universite de Montreal CHUM, Notre Dame Hospital, Department of Radiology and Interventional Neuroradiology Research Unit, Montreal, Quebec, Canada
    Interv Neuroradiol 17:147-53. 2011
    ..The FIAT study provides a scientific and ethical context to care for patients eligible for flow-diversion therapy...
  11. doi Endovascular parent artery occlusion for the treatment of wide-neck A1 segment aneurysms: a single-center experience
    E Tollard
    Department of Neuroradiology, Centre Hospitalier de l Universite de Montreal, Montreal, Canada
    AJNR Am J Neuroradiol 32:174-8. 2011
    ..None of the aneurysms ruptured on follow-up. In this series, parent artery occlusion was effective in treating wide-necked aneurysms arising from the A1 segment in patients with adequate collateral supply...
  12. pmc In vivo thrombogenicity of embolic protection systems for angioplasty and stenting
    J Raymond
    Radiology Department and Research Centre, CHUM Notre Dame Hospital, Montreal, Quebec, CANADA dr_jean_raymond hotmail com
    Interv Neuroradiol 13:329-33. 2007
    ..018). EPS differ in intrinsic thrombogenicity, a characteristic of the material that could be investigated in pre-clinical studies designed to optimize devices...
  13. pmc New Devices Designed to Improve the Long-Term Results of Endovascular Treatment of Intracranial Aneurysms. A Proposition for a Randomized Clinical Trial to Assess their Safety and Efficacy
    J Raymond
    Department of Radiology, Research center of Centre hospitalier de l Université de Montréal CHUM Notre Dame hospital Montréal, Quebec, Canada
    Interv Neuroradiol 10:93-102. 2004
    ..The scientific demonstration of an improved long-term efficacy, without significant compromise regarding safety, is mandatory before considering the widespread use of a new embolic device for the endovascular treatment of aneurysms...
  14. ncbi Management of atrial fibrillation in patients with congestive heart failure
    Marcio Lerch Sturmer
    Department of Medicine, Montreal Heart Institute, University of Montreal, Quebec, Canada
    Am J Geriatr Cardiol 14:91-4. 2005
    ..For a more definitive approach in managing these patients, the authors await further clinical trial data...
  15. ncbi Atrial fibrillation: basic and clinical research at the Montreal Heart Institute
    Denis Roy
    Department of Medicine and Research Centre, Montreal Heart Institute, Faculty of Medicine, University of Montreal, Quebec
    Can J Cardiol 21:1091-6. 2005
    ..Future directions at the Montreal Heart Institute are also briefly addressed...
  16. doi A new canine carotid artery bifurcation aneurysm model for the evaluation of neurovascular devices
    O Naggara
    Interventional Neuroradiology Research Unit, Department of Radiology, Centre Hospitalier de l Universite de Montreal, Notre Dame Hospital, Montreal, Canada
    AJNR Am J Neuroradiol 31:967-71. 2010
    ..Our first task was to verify that recurrences occurred after satisfactory coiling. A second aim of this preliminary work was to assess if the new model could recreate the technical challenges involved in bifurcation aneurysms...
  17. ncbi Sinus node dysfunction and sudden cardiac death following treatment with encainide
    R Lemery
    Department of Medicine, Montreal Heart Institute, Quebec, Canada
    Pacing Clin Electrophysiol 12:1607-12. 1989
    ..During a 6-month follow-up without antiarrhythmic drug treatment, this patient has had an uneventful course. We concluded that encainide can cause severe and life-threatening sinus node dysfunction...
  18. pmc A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials
    Jean Raymond
    Centre Hospitalier de l Universite de Montreal CHUM, Notre Dame Hospital, Department of Radiology, Montreal, Quebec, Canada
    Trials 12:64. 2011
    ..A special status should be reserved for what we would call 'clinical care trials', if we are to practice in a transparent and prospective fashion a medicine that leads to demonstrably better patient outcomes...
  19. ncbi [Public health professionals' perceptions regarding two dimensions of health promotion: the ecological approach and community participation]
    L Richard
    Faculté des sciences infirmières et GRIS, Universite de Montreal
    Can J Public Health 90:99-103. 1999
    ..However, limitations related to the work environment and to the theoretical underpinnings of these two components might impede the respondents' ability to integrate them into their practice...
  20. ncbi Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience
    Bernard Thibault
    Research Centre, Montreal Heart Institute, Quebec
    Can J Cardiol 20:195-9. 2004
    ..The recommendation is to anticoagulate these patients for a minimum of four weeks after cardioversion. Whether warfarin should be maintained for a longer period of time is unknown...
  21. pmc Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF)
    Maryse Palardy
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 24:709-13. 2008
    ....
  22. ncbi Atrial fibrillation and congestive heart failure
    Denis Roy
    Montreal Heart Institute and Department of Medicine, Universite de Montreal, Montreal, Quebec, Canada
    Curr Opin Cardiol 24:29-34. 2009
    ....
  23. doi Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction
    Kristina Lemola
    Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Canada
    Pacing Clin Electrophysiol 32:99-105. 2009
    ..We assessed whether AF predicts appropriate implantable cardioverter-defibrillator (ICD) shocks in patients with left ventricular dysfunction and explored modulators of risk...
  24. doi Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure
    Nancy Frasure-Smith
    Montreal Heart Institute Research Centre, Montreal, Quebec, Canada
    Circulation 120:134-40, 3p following 140. 2009
    ....
  25. ncbi Arrhythmias in adult congenital heart disease
    Paul Khairy
    Electrophysiology and Adult Congenital Heart Disease, Montreal Heart Institute, Montreal, QC H1T 1C8, Canada
    Expert Rev Cardiovasc Ther 4:83-95. 2006
    ..This review highlights the various types of brady- and tachyarrhythmias encountered in the more common forms of adult congenital heart disease and explores prognostic implications and therapeutic options...
  26. doi Morphometric ablation lesion characteristics comparing 4, 6, and 8 mm electrode-tip cryocatheters
    Paul Khairy
    Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
    J Cardiovasc Electrophysiol 19:1203-7. 2008
    ..Surface areas and volumes may be particularly sensitive to catheter tip-to-tissue contact angles with larger electrodes, as reflected by greater variability with 8 mm tips...
  27. ncbi Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF
    Stanley Nattel
    Department of Medicine and Research Center, Montreal Heart Institute and University of Montreal, Canada
    Card Electrophysiol Rev 7:211-4. 2003
    ....
  28. ncbi New approaches to atrial fibrillation management: a critical review of a rapidly evolving field
    Stanley Nattel
    Department of Medicine and Research Center, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada
    Drugs 62:2377-97. 2002
    ..In conclusion, significant advances are being made in the management of patients with AF but much more work remains to be done...
  29. ncbi Laser lead extraction in adult congenital heart disease
    Paul Khairy
    Adult Congenital Heart Center, Montreal Heart Institute, Montreal, QC, Canada
    J Cardiovasc Electrophysiol 18:507-11. 2007
    ..We sought to assess the safety and feasibility of laser lead extraction in ACHD...
  30. doi Liquid embolization material reduces the delivered radiation dose: clinical myth or reality?
    F Bing
    Department of Radiology, Centre Hospitalier Universite de Montreal, Montreal, Quebec, Canada
    AJNR Am J Neuroradiol 33:320-2. 2012
    ..To evaluate the impact of embolization material on radiation dose, we measured and compared the dose delivered to the center of an AVM model, before and following embolization with various materials in a LINAC...
  31. doi Rhythm control versus rate control for atrial fibrillation and heart failure
    Denis Roy
    Montreal Heart Institute and the Université de Montréal, Montreal, QC H1T 1C8, Canada
    N Engl J Med 358:2667-77. 2008
    ..However, the benefits and risks of this approach have not been adequately studied...
  32. ncbi Radiofrequency ablation of bundle branch reentrant tachycardia in a patient with atrial septal defect
    G G de Lima
    Department of Medicine, Montreal Heart Institute, Quebec
    Can J Cardiol 13:403-5. 1997
    ..Radiofrequency catheter ablation of the right bundle branch was successful, resulting in complete right bundle branch block and cure of her ventricular arrhythmia...
  33. pmc ICONE: An International Consortium of Neuro Endovascular Centres
    J Raymond
    Interventional Neuroradiology Research Unit, Department of Radiology, Universite de Montreal, CHUM Notre Dame Hospital, Montreal, Canada
    Interv Neuroradiol 14:203-8. 2008
    ..The Consortium is a realistic endeavour optimally structured to promote excellence through scientific appraisal of our treatments, and to accelerate technical progress while maximizing patients' safety and welfare...
  34. doi Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery
    Yanick Beaulieu
    Department of Medicine, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Anesthesiology 112:128-37. 2010
    ....
  35. ncbi Atrioventricular interval optimization and exercise tolerance
    P Khairy
    Department of Medicine and the Research Center, Montreal Heart Institute, Quebec, Canada
    Pacing Clin Electrophysiol 24:1534-40. 2001
    ..However, optimization of the AV interval with Doppler echocardiography at rest did not further improve exercise capacity...
  36. doi Pulmonary vein isolation for the treatment of atrial fibrillation: past, present and future
    Jean Benoit le Polain de Waroux
    Montreal Heart Institute, Universite de Montreal, Canada
    Future Cardiol 6:51-66. 2010
    ..Pulmonary vein isolation has emerged as an effective treatment in selected patients. In this paper, the past and present roles of pulmonary vein isolation are described and the future developments of this technique are explored...
  37. ncbi Prognostic significance of ventricular arrhythmias post-myocardial infarction
    Paul Khairy
    Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
    Can J Cardiol 19:1393-404. 2003
    ..Inhospital mortality is higher when ventricular fibrillation presents in the acute phase but long term prognosis is not adversely affected...
  38. doi Cryoablation outcomes for AV nodal reentrant tachycardia comparing 4-mm versus 6-mm electrode-tip catheters
    Lena Rivard
    Electrophysiology Service, Montreal Heart Institute, Montreal, Quebec, Canada
    Heart Rhythm 5:230-4. 2008
    ..Cryoablation is increasingly used to treat atrioventricular nodal reentrant tachycardia (AVNRT). It is unknown whether larger electrode-tip cryocatheters improve outcomes without compromising safety...
  39. ncbi A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
    Denis Roy
    Montreal Heart Institute, University of Montreal, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8
    J Am Coll Cardiol 44:2355-61. 2004
    ..The purpose of this study was to determine the efficacy and safety of intravenous RSD1235 in terminating recent onset atrial fibrillation (AF)...
  40. ncbi Sudden death and hypertrophic cardiomyopathy: a review
    Hung Q Ly
    Clinical Electrophysiology Service, Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
    Can J Cardiol 21:441-8. 2005
    ..Thus, tools are now available to identify and treat high-risk patients with hypertrophic cardiomyopathy...
  41. doi Suitability of cerebral aneurysms for endovascular treatment: Evolution of criteria with technological developments
    D Roy
    Departement de Radiologie, Centre Hospitalier de l Universite de Montreal, Hopital Notre Dame, 1560 Sherbrooke Est, Pavillon Simard, suite Z12909, Montreal, Quebec H2L4M1, Canada
    Neurochirurgie 58:87-96. 2012
    ..In this paper, we will make a review of the anatomical factors associated with poor anatomical results as well as technological developments aiming at improvement of aneurysm healing...
  42. ncbi Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients
    V Michaud
    Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada
    Clin Pharmacol Ther 83:740-8. 2008
    ..Thus, combination of a phenotypic measure to CYP2C9-VKORC1 genotypes represents a useful strategy to predict warfarin doses in patients receiving multiple drugs (11+/-4 drugs/day)...
  43. ncbi Endovascular treatment of unruptured aneurysms
    D Roy
    Department of Radiology, University of Montreal, Quebec, Canada
    Stroke 32:1998-2004. 2001
    ..We sought to better define the morbidity of endovascular Guglielmi detachable coil (GDC) treatment of unruptured cerebral aneurysms and to discuss its role in the prevention of subarachnoid hemorrhage...
  44. ncbi Anodal right ventricular capture during left ventricular stimulation in CRT-implantable cardioverter defibrillators
    Bernard Thibault
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    Pacing Clin Electrophysiol 28:613-9. 2005
    ..The RV leads used in these systems are different from pacemaker leads: they have a larger diameter and shocking coils, which may affect the occurrence of anodal capture...
  45. ncbi Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm
    Mario Talajic
    Montreal Heart Institute, Montreal, Quebec
    Can J Cardiol 21:19B-25B. 2005
    ..Drugs that are recommended and frequently used to convert AF and maintain sinus rhythm are reviewed, and the toxicity of antiarrhythmic drug toxicity is discussed...
  46. doi Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial
    Denis Roy
    Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
    Circulation 117:1518-25. 2008
    ..The present study assessed the efficacy and safety of vernakalant hydrochloride (RSD1235), a novel compound, for the conversion of atrial fibrillation (AF)...
  47. doi Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation
    Mario Talajic
    Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada
    J Am Coll Cardiol 55:1796-802. 2010
    ..The goal of this study was to evaluate the relationship between the presence of sinus rhythm and outcomes in patients with a history of congestive heart failure (CHF) and atrial fibrillation (AF)...
  48. ncbi Shocking truths about implantable cardioverter defibrillator monitoring zones
    Fadi Mansour
    Electrophysiology Service, Montreal Heart Institute, Montreal, Quebec, Canada
    Pacing Clin Electrophysiol 30:1146-8. 2007
    ..In the absence of a monitoring zone, device therapy would not have been expected. We explore the mechanisms by which monitoring zones could potentially contribute to inappropriate ICD therapy and offer trouble-shooting tips...
  49. pmc Pulmonary vein isolation and left atrial catheter ablation using a three-dimensional navigation system for the treatment of atrial fibrillation
    Laurent Macle
    Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 25:e169-72. 2009
    ..Catheter ablation strategies targeting PVs and the posterior LA may be further refined by incorporating technology beyond standard fluoroscopy...
  50. ncbi Cryothermal slow pathway modification for atrioventricular nodal reentrant tachycardia
    Paul Khairy
    Electrophysiology Service, Montreal Heart Institute, 5000 Belanger St East, Montreal, Quebec, Canada H1T 1C8
    Europace 9:909-14. 2007
    ..persistent dual atrioventricular (AV) nodal physiology with or without echo beats...
  51. ncbi Beta-radiation for the creation of linear lesions in the canine atrium
    Peter G Guerra
    Department of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger East, Montreal, Quebec, Canada H1T 1C8
    Circulation 110:911-4. 2004
    ..The purpose of this study was to evaluate beta-radiation as a novel energy source for creating linear myocardial lesions...
  52. ncbi Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter
    Bramah N Singh
    Cardiology Division, Veterans Affairs Greater Los Angeles Healthcare System and the David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA
    N Engl J Med 357:987-99. 2007
    ..Dronedarone is a new antiarrhythmic agent pharmacologically related to amiodarone but developed to reduce the risk of side effects...
  53. ncbi Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation
    Paul Dorian
    Department of Medicine, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
    Am Heart J 143:984-90. 2002
    ..The impact of atrial fibrillation (AF) and its treatment on health-related quality of life (QOL) is not well understood. We assessed QOL in patients with symptomatic AF participating in the Canadian Trial of Atrial Fibrillation...
  54. ncbi Identification of atrial tissue in pulmonary veins using intravascular ultrasound
    Peter G Guerra
    Department of Medicine, Montreal Heart Institute
    J Am Soc Echocardiogr 16:982-7. 2003
    ..Ectopic beats initiating AF always originated from these areas. PVs without thickening on IVUS did not have these potentials...
  55. pmc The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care
    Robyn Tamblyn
    Department of Medicine, McGill University, Montreal, Que
    CMAJ 169:549-56. 2003
    ....
  56. ncbi Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT)
    John D Fisher
    Montefiore Medical Center Albert Einstein College of Medicine, Bronx, New York, USA
    Am J Cardiol 100:76-83. 2007
    ..The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT...
  57. pmc A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale
    Paul Dorian
    Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario, Canada
    Can J Cardiol 22:383-6. 2006
    ..Quantifying the effect of AF on patient well-being is important but there is no simple, commonly accepted measure of the effect of AF on quality of life (QoL). Current QoL measures are cumbersome and impractical for clinical use...